Animal models for COVID-19: advances, gaps and perspectives

C Fan, Y Wu, X Rui, Y Yang, C Ling, S Liu… - Signal transduction and …, 2022 - nature.com
Abstract COVID-19, caused by SARS-CoV-2, is the most consequential pandemic of this
century. Since the outbreak in late 2019, animal models have been playing crucial roles in …

[HTML][HTML] 'Spikeopathy': COVID-19 spike protein is pathogenic, from both virus and vaccine mRNA

PI Parry, A Lefringhausen, C Turni, CJ Neil, R Cosford… - Biomedicines, 2023 - mdpi.com
The COVID-19 pandemic caused much illness, many deaths, and profound disruption to
society. The production of 'safe and effective'vaccines was a key public health target. Sadly …

Animal models in SARS-CoV-2 research

H Chu, JFW Chan, KY Yuen - Nature methods, 2022 - nature.com
Animal models in SARS-CoV-2 research | Nature Methods Skip to main content Thank you for
visiting nature.com. You are using a browser version with limited support for CSS. To obtain the …

Divergent trajectory of replication and intrinsic pathogenicity of SARS-CoV-2 Omicron post-BA. 2/5 subvariants in the upper and lower respiratory tract

B Hu, JFW Chan, Y Liu, H Liu, YX Chen, H Shuai… - …, 2024 - thelancet.com
Summary Background Earlier Omicron subvariants including BA. 1, BA. 2, and BA. 5
emerged in waves, with a subvariant replacing the previous one every few months. More …

Neutralization against Omicron subvariants after BA. 5/BF. 7 breakthrough infection weakened as virus evolution and aging despite repeated prototype-based …

H Wang, Q Xue, H Zhang, G Yuan, X Wang… - Emerging Microbes & …, 2023 - Taylor & Francis
Background: Omicron had swept the mainland China between December 2022 and January
2023, while SARS-CoV-2 still continued to evolve. To fully prepare for the next wave, it's …

SARS-CoV-2 ORF8 accessory protein is a virulence factor

M Bello-Perez, J Hurtado-Tamayo, AZ Mykytyn… - Mbio, 2023 - Am Soc Microbiol
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) encodes six accessory
proteins (3a, 6, 7a, 7b, 8, and 9b) for which limited information is available on their role in …

Multicomponent intranasal adjuvant for mucosal and durable systemic SARS-CoV-2 immunity in young and aged mice

S Jangra, JJ Landers, G Laghlali, R Rathnasinghe… - npj Vaccines, 2023 - nature.com
Abstract Multiple FDA-approved SARS-CoV-2 vaccines currently provide excellent
protection against severe disease. Despite this, immunity can wane relatively fast …

Adaptation of SARS-CoV-2 to ACE2H353K mice reveals new spike residues that drive mouse infection

K Li, A Verma, P Li, ME Ortiz, GM Hawkins… - Journal of …, 2024 - Am Soc Microbiol
ABSTRACT The Coronavirus Disease 2019 (COVID-19) pandemic continues to cause
extraordinary loss of life and economic damage. Animal models of severe acute respiratory …

A C57BL/6 mouse model of SARS-CoV-2 infection recapitulates age-and sex-based differences in human COVID-19 disease and recovery

MA Davis, K Voss, JB Turnbull, AT Gustin, M Knoll… - Vaccines, 2022 - mdpi.com
We present a comprehensive analysis of SARS-CoV-2 infection and recovery using wild
type C57BL/6 mice and a mouse-adapted virus, and we demonstrate that this is an ideal …

Risk assessment of SARS-CoV-2 replicating and evolving in animals

J Zhao, M Kang, H Wu, B Sun, G Baele, WT He… - Trends in …, 2024 - cell.com
The retransmissions of SARS-CoV-2 from several mammals–primarily mink and white-tailed
deer–to humans have raised concerns for the emergence of a new animal-derived SARS …